ProGP388 (Cj1032 (Membrane fusion component multid

Home -> ProGPdb -> Search ProGP -> Display data

ProGP ID ProGP388 (Cj1032 (Membrane fusion component multid
Validation Status Characterized
Organism Information
Organism NameCampylobacter jejuni HB93-13
Domain Bacteria
Classification Family: Campylobacteraceae
Order: "Campylobacterales"
Class: "Epsilonproteobacteria"
Division or phylum: "Proteobacteria"
Taxonomic ID (NCBI) 192222
Genome Information
GenBank NC_002163.1.
EMBL AL111168
Organism Additional Information Campylobacter jejuni is a microaerophilic, Gram-negative, human pathogen that is the major cause of bacterial food-borne diarrhoea (gastroenteritis). It is most frequently responsible for a form of post-infection neuromuscular paralysis known as Guillain Barre' syndrome. It also leads to an immunoproliferative small intestine disease that is a rare malignant lymphoma of the intestine. Motility is essential for pathogenicity.
Gene Information
Gene NamecmeE
NCBI Gene ID 905324.
GenBank Gene Sequence NC_002163.1.
Protein Information
Protein NameCj1032 (Membrane fusion component multidrug efflux system)
UniProtKB/SwissProt ID Q0P9M0
NCBI RefSeq WP_002858463.1
EMBL-CDSCAL35150.1.
UniProtKB Sequence >tr|Q0P9M0|Q0P9M0_CAMJE Membrane fusion component of efflux system (Mutlidrug efflux system CmeDEF) OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) GN=cmeE PE=3 SV=1 MKKILFLLLVFNCAFGEEIYASFNVEASKQSKLALESIGLVQKIPVEIGQKVSKGELLLA LDQESEKIALQNAQNSYQLALVEYENTKSRMQKIKAVENVIDKQSYEDMKAKFDAANLNL NKAKINIAYYKNIMAKKELRAPYDAIIANKFIQVGEGVGGVAQPLIEIFSYPQSKLILSF DEKYKDKVRLGDDFFYKIDQNGTELKGKINLIYPSIEVKTRKIYAEVQTTNLTPGLFGEG RIITKD
Sequence length 246 AA
Glycosylation Status
Glycosylation Type N- (Asn) linked
Experimentally Validated Glycosite(s) in Full Length ProteinN201
Glycosite(s) Annotated Protein Sequence >tr|Q0P9M0|Q0P9M0_CAMJE Membrane fusion component of efflux system (Mutlidrug efflux system CmeDEF) OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) GN=cmeE PE=3 SV=1 MKKILFLLLVFNCAFGEEIYASFNVEASKQSKLALESIGLVQKIPVEIGQKVSKGELLLA LDQESEKIALQNAQNSYQLALVEYENTKSRMQKIKAVENVIDKQSYEDMKAKFDAANLNL NKAKINIAYYKNIMAKKELRAPYDAIIANKFIQVGEGVGGVAQPLIEIFSYPQSKLILSF DEKYKDKVRLGDDFFYKIDQN*(201)GTELKGKINLIYPSIEVKTRKIYAEVQTTNLTPGLFGEG RIITKD
Sequence Around Glycosites (21 AA) GDDFFYKIDQNGTELKGKINL
Technique(s) used for Glycosylation DetectionSoybean Lectin Affinity Enrichment and ZIC-HILIC enrichment
Technique(s) used for Glycosylated Residue(s) Detection Reversed Phase LC-Tandem CID/HCD-MS, CID/ETD-MS and ESI (CID)-MS/MS after enrichment using graphite microcolumns
Glycan Information
Glycan Annotation Heptasaccharide GalNAc- α1,4-GalNAc- α1,4-(Glc β1,3)-GalNAc- α1,4-GalNAc- α1,4-GalNAc- α1,3-Bac- β1 where Bac is bacillosamine (2,4-diacetamido-2,4,6-trideoxyglucopyranose)
BCSDB ID20059
Technique(s) used for Glycan Identification Reversed Phase LC-Tandem CID/HCD-MS
Literature
Year of Identification2011
Year of Identification Month Wise2011.2.10
Year of Validation 2011